Skip to content

Clinical trials

Anemia trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Not applicable Clear all

372 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20024
20037
20045
200513
20066
200711
20087
200916
201026
201113
201214
201313
201421
201517
201618
201718
201820
201920
202012
20218
202213
202317
202420
202516
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed243
Unknown status43
Recruiting21
Withdrawn18
Terminated18
Not yet recruiting16
Active, not recruiting9
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London School of Hygiene and Tropical Medicine14
Swiss Federal Institute of Technology11
Aga Khan University8
International Food Policy Research Institute8
Harvard School of Public Health (HSPH)7
Masimo Corporation7
Cornell University6
Ortho Pharmaceuticals6
Emory University5
University of California, Davis5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia372
Anemia, Iron-Deficiency46
Iron Deficiencies44
Malaria31
Malnutrition22
Growth Disorders13
Renal Insufficiency, Chronic11
Premature Birth10
Acquired Immunodeficiency Syndrome9
Inflammation9

Trials

Showing 76 to 100 of 372. Each trial links to its page on Pharma Observatory.

272 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.